The Trump administration has cut off federal health care research grants without warning, leaving researchers and institutions across the country in sudden financial uncertainty.
According to a report by NOTUS, the grant terminations came without advance notice, disrupting ongoing studies and forcing institutions to make rapid decisions about research staff and project continuity. The cuts affected a range of health research areas, though specific programs targeted were not fully detailed at the time of the report.
Researchers and university administrators said the abrupt nature of the terminations made planning nearly impossible. Federal research grants typically fund multi-year studies, and the sudden loss of that funding mid-project can mean collected data goes unpublished, clinical trial participants lose access to study-related care, and research staff face layoffs.
The cuts are part of a broader pattern of reductions to federal health and science spending under the current administration. Earlier this year, the administration also moved to reduce staffing at agencies including the National Institutes of Health and the Centers for Disease Control and Prevention.
Health research advocates have argued that cuts of this kind have consequences that extend beyond individual studies. Research funded through federal grants often forms the foundation for treatment guidelines, drug approvals, and public health policy. Disrupting that pipeline, they argue, can delay advances in medicine for years.
The full scope of which grants were terminated and how many researchers were affected had not been fully disclosed as of the report's publication.